Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pleural Effusion | 1 | 2024 | 51 | 0.880 |
Why?
|
| Serratia marcescens | 4 | 2016 | 18 | 0.820 |
Why?
|
| Caenorhabditis elegans | 5 | 2016 | 296 | 0.740 |
Why?
|
| Self-Fertilization | 4 | 2016 | 5 | 0.700 |
Why?
|
| Office Visits | 2 | 2016 | 87 | 0.610 |
Why?
|
| Hand | 2 | 2016 | 157 | 0.560 |
Why?
|
| Cancer Pain | 1 | 2017 | 27 | 0.520 |
Why?
|
| Analgesics | 1 | 2017 | 194 | 0.470 |
Why?
|
| Cannabinoids | 1 | 2017 | 154 | 0.460 |
Why?
|
| Host-Pathogen Interactions | 5 | 2016 | 355 | 0.450 |
Why?
|
| Perception | 1 | 2015 | 347 | 0.410 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 639 | 0.370 |
Why?
|
| Genetic Variation | 1 | 2016 | 937 | 0.350 |
Why?
|
| Biological Evolution | 4 | 2016 | 435 | 0.330 |
Why?
|
| Mental Disorders | 1 | 2017 | 1035 | 0.300 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 2104 | 0.230 |
Why?
|
| Ventricular Pressure | 1 | 2024 | 45 | 0.230 |
Why?
|
| Metagenomics | 1 | 2024 | 156 | 0.210 |
Why?
|
| Sputum | 1 | 2024 | 302 | 0.200 |
Why?
|
| Selection, Genetic | 2 | 2016 | 252 | 0.190 |
Why?
|
| Reproduction | 2 | 2014 | 198 | 0.180 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 542 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2024 | 529 | 0.180 |
Why?
|
| Genetic Fitness | 2 | 2016 | 56 | 0.140 |
Why?
|
| Serratia | 1 | 2016 | 3 | 0.130 |
Why?
|
| Microbiota | 1 | 2024 | 734 | 0.130 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2016 | 4 | 0.130 |
Why?
|
| Inbreeding | 1 | 2016 | 18 | 0.130 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 134 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 264 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2024 | 1067 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2015 | 127 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 610 | 0.110 |
Why?
|
| Health Literacy | 1 | 2016 | 162 | 0.110 |
Why?
|
| Orthopedics | 1 | 2016 | 136 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 462 | 0.100 |
Why?
|
| Sex | 1 | 2011 | 5 | 0.090 |
Why?
|
| Heart Failure | 1 | 2024 | 2148 | 0.090 |
Why?
|
| Logistic Models | 1 | 2015 | 1989 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 521 | 0.090 |
Why?
|
| Time Factors | 2 | 2016 | 6550 | 0.070 |
Why?
|
| Middle Aged | 3 | 2017 | 31177 | 0.070 |
Why?
|
| Humans | 5 | 2024 | 129847 | 0.060 |
Why?
|
| Freezing | 1 | 2024 | 87 | 0.060 |
Why?
|
| Female | 5 | 2024 | 68829 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2024 | 94 | 0.050 |
Why?
|
| Respiratory System | 1 | 2024 | 156 | 0.050 |
Why?
|
| Hermaphroditic Organisms | 2 | 2014 | 2 | 0.050 |
Why?
|
| Animals | 5 | 2016 | 35409 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2017 | 10241 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2024 | 646 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 778 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 486 | 0.050 |
Why?
|
| Aged | 2 | 2016 | 22107 | 0.040 |
Why?
|
| Male | 4 | 2024 | 63759 | 0.040 |
Why?
|
| Bacteria | 1 | 2024 | 814 | 0.040 |
Why?
|
| Hybridization, Genetic | 1 | 2016 | 73 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 85 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 194 | 0.030 |
Why?
|
| Extinction, Biological | 1 | 2011 | 33 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 2011 | 55 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 376 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 35634 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 3706 | 0.020 |
Why?
|